Literature DB >> 23328804

Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity.

A L Ells1, G A Gole, P Lloyd Hildebrand, A Ingram, C M Wilson, R Geoff Williams.   

Abstract

BACKGROUND: Current methods of treating the avascular retina with laser photocoagulation for severe retinopathy of prematurity (ROP) are not completely effective in the reduction of visual morbidity. We report a case series in which additional laser treatment, called 'posterior laser', was delivered posterior to the neovascular ridge, for eyes with severe stage 3 ROP in zone II with avascular retina posterior to the ridge.
DESIGN: Retrospective chart review. PARTICIPANTS: Infants who underwent laser treatment, posterior to the neovascular ridge for severe ROP at the Alberta Children's Hospital, between January 2005 and October 2008.
METHODS: Charts were reviewed for 18 eyes of 11 patients and collected information included demographic data, clinical examination results, and digital retinal images. MAIN OUTCOME MEASURES: Structural and functional outcomes of treatment.
RESULTS: Four (22%) of 18 eyes received 'posterior laser' as primary treatment and the remainder of eyes (78%) received 'posterior laser' following previous laser photocoagulation anterior to the neovascular ridge. Mean birthweight was 688 g (552-930) and mean gestational age was 24 weeks (23-28). There were no complications because of the posterior laser treatment. In all, 16 of 18 eyes experienced rapid regression of the ridge and subsequent decrease in vascular dilation and tortuosity within 1 week. Two eyes required vitrectomy for 4A retinal detachment; however, no eyes developed stage 4B ROP.
CONCLUSION: Posterior to the ridge laser in the setting of the morphological criteria described had no increased safety concerns and resulted in rapid regression of ROP with good outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23328804      PMCID: PMC3626006          DOI: 10.1038/eye.2012.302

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  27 in total

1.  Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity.

Authors:  Ruth Axer-Siegel; Moshe Snir
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

2.  Prevention of cicatricial retrolental fibroplasia by cryotherapy.

Authors:  N W Hindle; J Leyton
Journal:  Can J Ophthalmol       Date:  1978-10       Impact factor: 1.882

3.  The rate and route of fluid resorption from the subretinal space of the rabbit.

Authors:  D A Frambach; M F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-03       Impact factor: 4.799

4.  Retrolental Fibroplasia. II. Pathologic correlation.

Authors:  B J Kushner; D Essner; I J Cohen; J T Flynn
Journal:  Arch Ophthalmol       Date:  1977-01

5.  Chorioretinal adhesion after argon laser photocoagulation.

Authors:  H L Kain
Journal:  Arch Ophthalmol       Date:  1984-04

6.  Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

Authors:  E A Pierce; E D Foley; L E Smith
Journal:  Arch Ophthalmol       Date:  1996-10

Review 7.  Pathogenesis of retinopathy of prematurity.

Authors:  Lois E H Smith
Journal:  Growth Horm IGF Res       Date:  2004-06       Impact factor: 2.372

8.  Can the diode laser (810 nm) effectively produce chorioretinal adhesion?

Authors:  U Menchini; G Trabucchi; R Brancato; A Cappellini
Journal:  Retina       Date:  1992       Impact factor: 4.256

9.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity.

Authors:  M O'Keefe; J Burke; K Algawi; M Goggin
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

View more
  9 in total

1.  One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.

Authors:  Murat Gunay; Gokhan Celik; Fahri Ovali; Huseyin Yetik; Alev Aktas; Betul Onal Gunay
Journal:  Int Ophthalmol       Date:  2014-11-09       Impact factor: 2.031

2.  Response to Dr Uparkar and Dr Kaul.

Authors:  A L Ells; G A Gole; P Lloyd Hildebrand; A Ingram; C M Wilson; R Geoff Williams
Journal:  Eye (Lond)       Date:  2013-05-17       Impact factor: 3.775

3.  Laser barrage anterior to ridge in threshold ROP-caveat.

Authors:  M Uparkar; S Kaul
Journal:  Eye (Lond)       Date:  2013-05-17       Impact factor: 3.775

4.  Development of astrocytes in the vertebrate eye.

Authors:  Chenqi Tao; Xin Zhang
Journal:  Dev Dyn       Date:  2014-10-13       Impact factor: 3.780

5.  Treatment for retinopathy of prematurity in an infant with adenoviral conjunctivitis.

Authors:  Murat Gunay; Gokhan Celik; Rahim Con
Journal:  Case Rep Pediatr       Date:  2015-03-19

6.  Posterior laser barrage in advancing retinopathy of prematurity: A prospective randomized study.

Authors:  Ruchir Tewari; Parijat Chandra; Ramesh Agarwal; Rajvardhan Azad
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

7.  Retinopathy of prematurity: a review of epidemiology and current treatment strategies.

Authors:  Eun Hee Hong; Yong Un Shin; Heeyoon Cho
Journal:  Clin Exp Pediatr       Date:  2021-10-12

8.  Exudative Retinal Detachment After ROP Laser Photocoagulation.

Authors:  Henry Zou; Lauren Fletcher-Morehouse
Journal:  Cureus       Date:  2022-08-11

Review 9.  Graphene Oxide-Based Nanomaterials: An Insight into Retinal Prosthesis.

Authors:  Jia-Wei Yang; Zih-Yu Yu; Sheng-Jen Cheng; Johnson H Y Chung; Xiao Liu; Chung-Yu Wu; Shien-Fong Lin; Guan-Yu Chen
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.